Concepedia

Author

Eunice Y. Lau

University of Hong KongORCID

Also Known As

E Y Lau, E Y T Lau, Eunice Lau, Eunice Y-T Lau, Eunice Y. Lau, Eunice Y. T. Lau, Eunice Y.T. Lau, Eunice Yuen Ting Lau, Eunice Yuen-Ting Lau, Eunice Yuen‐Ting Lau

84

Publications

2.4K

Citations

20

H-Index

27

Concepts

All Affiliations

University of Hong KongHong Kong Polytechnic UniversityChinese University of Hong KongQueen Elizabeth HospitalQueen Mary Hospital
EY

About

Eunice Y. Lau is an author at University of Hong Kong specializing in cell biology, medicine, and hepatocellular carcinoma.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

4

4

596

2

Cell Biology

4

4

596

3

Health Sciences

3

3

422

4

Hepatology

2

2

370

5

Immunology

1

1

41

Eunice Y. Lau

×

20

Publications

2.1K

Citations

18

H-Index

YearCitations

Cancer-Associated Fibroblasts Regulate Tumor-Initiating Cell Plasticity in Hepatocellular Carcinoma through c-Met/FRA1/HEY1 Signaling

Eunice Y. Lau, Jessica Lo, Bowie Y. Cheng,

Cell Reports

2016

329

Blockade of Cd47-Mediated Cathepsin S/Protease-Activated Receptor 2 Signaling Provides a Therapeutic Target for Hepatocellular Carcinoma

Terence K. Lee, Vincent Chi-Ho Cheung, Ping Lu,

Hepatology

2014

210

SENP1 promotes hypoxia-induced cancer stemness by HIF-1α deSUMOylation and SENP1/HIF-1α positive feedback loop

Chun‐Ping Cui, Carmen Chak‐Lui Wong, Alan Ka‐Lun Kai,

Gut

2017

210

Nuclear factor kappa B–mediated CD47 up‐regulation promotes sorafenib resistance and its blockade synergizes the effect of sorafenib in hepatocellular carcinoma in mice

Jessica Lo, Eunice Y. Lau, Rachel Hiu Ha Ching,

Hepatology

2015

206

Octamer 4/microRNA‐1246 signaling axis drives Wnt/β‐catenin activation in liver cancer stem cells

Stella Chai, Kai‐Yu Ng, Man Tong,

Hepatology

2016

188

Stearoyl-CoA desaturase regulates sorafenib resistance via modulation of ER stress-induced differentiation

Mark Kin Fai, Eunice Y. Lau, Hoi-Wing Leung,

Journal of Hepatology

2017

174

IRAK1 Augments Cancer Stemness and Drug Resistance via the AP-1/AKR1B10 Signaling Cascade in Hepatocellular Carcinoma

Bowie Y. Cheng, Eunice Y. Lau, Hoi-Wing Leung,

Cancer Research

2018

130

EPHB2 Activates β-Catenin to Enhance Cancer Stem Cell Properties and Drive Sorafenib Resistance in Hepatocellular Carcinoma

Hoi-Wing Leung, Carmen Oi Ning Leung, Eunice Y. Lau,

Cancer Research

2021

127

Caspase-3–Induced Activation of SREBP2 Drives Drug Resistance via Promotion of Cholesterol Biosynthesis in Hepatocellular Carcinoma

Etienne Ho Kit Mok, Carmen Leung, Lei Zhou,

Cancer Research

2022

92

Overriding Adaptive Resistance to Sorafenib Through Combination Therapy With Src Homology 2 Domain–Containing Phosphatase 2 Blockade in Hepatocellular Carcinoma

Carmen Oi Ning Leung, Man Tong, Katherine Po Sin Chung,

Hepatology

2019

81

Page 1